Anavex Life Sciences (AVXL) Net Equity Issued and Repurchased (2010 - 2025)
Anavex Life Sciences (AVXL) posted Net Equity Issued and Repurchased of $1.26 million for fiscal Q4 2025 (quarter ended Sep 30, 2025), compared with $89,000 a year earlier and up 962.2% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Net Equity Issued and Repurchased came in at $2.94 million, up 325.9% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Net Equity Issued and Repurchased was $691,000 in FY2024 (-61.1%), $1.78 million in FY2023 (-91.5%), $20.99 million in FY2022 (-86.3%) and $153.22 million in FY2021 (+432.9%).
- The fiscal Q4 2025 figure stands as the highest quarterly Net Equity Issued and Repurchased since fiscal Q3 2023.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in 1 of the last five quarters, with growth averaging 83.2%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was fiscal Q2 2025, with growth of 760.6%; the weakest was fiscal Q4 2021, with a decline of 100.0%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior fiscal quarters was $119,000 (Q3 2025), $852,000 (Q2 2025) and $708,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 708,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | -24.91 Mn |
| Jun 30, 2023 | 8.53 Mn |
| Mar 31, 2023 | 17.90 Mn |
| Dec 31, 2022 | 258,000.00 |
| Sep 30, 2022 | 2,852.00 |
| Jun 30, 2022 | 6.58 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 254.00 |
| Jun 30, 2021 | 91.28 Mn |
| Mar 31, 2021 | 35.69 Mn |
| Dec 31, 2020 | 26.24 Mn |
API Access
Anavex Life Sciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();